Accessibility Menu
Curaleaf logo

Curaleaf

(OTC) CURLF

Current Price$9.35
Market Cap$3.06BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2018)-52%
5 Year-77%
1 Year+210%
1 Month-2%
Curaleaf last closing stock price
MetricPriceDate
Last closeUSD 9.352026-07-17
Curaleaf stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.16%USD 9.462026-07-10
1 month-2.4%USD 9.582026-06-17
3 month+14.58%USD 8.162026-04-17
Year to date+23.68%USD 7.562025-12-31
1 year+209.81%USD 3.022025-07-17
3 year-11.46%USD 10.562023-07-18
5 year-76.6%USD 39.972021-07-16
Since inception-52.49%USD 19.682018-10-30

Curaleaf Financials at a Glance

Market Cap

$3.06BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.30B

Net Income (TTM)

-$102.97M

EPS (TTM)

-$0.44

P/E Ratio

-21.46

Dividend

$0.00

Beta (Volatility)

0.90 (Low)

Price

$9.35

Volume

69,177

Open

$9.28

Previous Close

$9.35

Daily Range

$9.01 - $9.40

52-Week Range

$2.92 - $15.15

Estimated Earnings Date

Aug 5, 2026

CURLF News

GettyImages-1477090373-1200x800-5b2df79

Better Buy: Green Thumb Industries vs. Curaleaf Holdings

Thomas NielJun 1, 2026
A cannabis leaf on top of a $100 bill.

Best Cannabis ETFs to Buy in 2026 and How to Invest

Keith SpeightsMay 8, 2026
An excited investor looking at a chart.

3 Cannabis Stocks That Could Soar After Marijuana Rescheduling

David Jagielski, CPAApr 28, 2026
Person using a vaping product

Why Curaleaf Holdings Stock Popped by Almost 25% on Tuesday

Eric VolkmanDec 16, 2025
Smiling person in a grow room full of marijuana plants

Why Investors Were Buzzing About Curaleaf Stock Today

Eric VolkmanDec 4, 2025
US flag hidden under a thicket of marijuana plants.

Prediction: President Trump Will Legalize Marijuana in 2026

Rich SmithOct 5, 2025
American flag with marijuana plants in the background.

Why Curaleaf Stock Dropped Today

Rich SmithSep 30, 2025
Person lighting and consuming a marijuana cigarette

Why Curaleaf Stock Was Smoking the Market Today

Eric VolkmanSep 23, 2025
Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Curaleaf

Curaleaf Holdings, Inc. is a leading cannabis company engaged in the retail and wholesale of cannabis products across the United States and internationally. The company operates licensed cultivation and pharma-grade cannabis processing facilities, supplying products to various global markets.

Products and Services
  • Retail and wholesale cannabis products for medical and adult-use markets
  • Licensed cultivation and processing facilities for high-quality cannabis
  • Medical cannabis clinics and pharmacy services
Growth Outlook
  • Expansion into international markets, including Australia and Europe
  • Increased retail footprint with new dispensaries planned
  • Focus on product innovation to capture market share
Financial Highlights
  • Q1 2026 revenue of $319.7 million, showing strong sales performance
  • Trailing twelve months gross profit margin at 40.8%, indicating operational efficiency
  • Net income of $68.8 million in Q1 2026, reflecting improved profitability
Curaleaf Holdings, Inc. has established itself as a significant player in the cannabis industry, with a diverse range of products and services catering to both medical and recreational markets. The company's strategic focus on expanding its retail presence and entering new international markets positions it well for future growth. Recent financial performance highlights a robust revenue stream and improving profitability, suggesting a positive trajectory for the company. With a commitment to innovation and operational efficiency, Curaleaf is poised to capitalize on the growing demand for cannabis products.
AI Generated • Jul 19, 2026

Industry

Pharmaceuticals

Sector

Health Care

CEO

Boris Alexis Jordan

Website

www.curaleaf.com

Headquarters

Stamford, CT 06902, US

CURLF Financials

Key Financial Metrics (TTM)

Gross Margin

40.75%

Operating Margin

0.85%

Net Income Margin

-7.93%

Return on Equity

-12.61%

Return on Capital

1.45%

Return on Assets

-3.65%

Earnings Yield

-4.66%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.06BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

326.75M

Volume

69.18K

Avg. Volume

392.44K

Financials (TTM)

Gross Profit

$528.91M

Operating Income

$11.07M

EBITDA

$184.66M

Operating Cash Flow

$118.37M

Capital Expenditure

-$64.21M

Free Cash Flow

$54.15M

Cash & ST Invst.

$106.48M

Total Debt

$1.04B

Curaleaf Performance Analysis

Curaleaf annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 1,275,420,0006.6%
20232023-12-31USD 1,346,632,0005.6%
20242024-12-31USD 1,334,299,000-0.9%
20252025-12-31USD 1,268,135,000-5.0%
Curaleaf sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-303.4%
Q32025-09-300.2%
Q42025-12-315.6%
Q12026-03-31-5.5%
Curaleaf annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -1.5676.6%
20232023-12-31USD -1.17-25.4%
20242024-12-31USD -0.96-17.2%
20252025-12-31USD -1.0811.6%
Curaleaf sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3012.6%
Q32025-09-30-3.2%
Q42025-12-31-6.8%
Q12026-03-31214.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$319.74M

+3.5%

Gross Profit

$121.91M

+2.1%

Gross Margin

38.13%

N/A

Market Cap

$3.06BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$547.99K

N/A

Employees

5,575

N/A

Net Income

$68.83M

+213.1%

EBITDA

$30.14M

-50.5%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$106.48M

-12.6%

Total Debt

$1.04B

-1.6%

Accounts Receivable

$78.17M

+18.6%

Inventory

$0.00

-100.0%

Long Term Debt

$961.24M

-2.2%

Short Term Debt

$83.46M

+6.3%

Return on Assets

-3.65%

N/A

Return on Invested Capital

0.44%

N/A

Free Cash Flow

$3.95M

-83.5%

Operating Cash Flow

$20.70M

-48.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LBTSFAlmirall, S.A.
$15.35-0.78%
HTSUFHisamitsu Pharmaceutical Co., Inc.
$29.00+0.00%
TCNNFTrulieve Cannabis Corp.
$8.30-3.82%
CASBFCanSino Biologics Inc.
$3.15+20.96%

Trending Stocks

Symbol / CompanyPricePrice Chg
NFLXNetflix
$68.95-0.07%
INTCIntel
$95.04-0.02%
NOKNokia
$10.12-0.03%
JOBYJoby Aviation
$7.23-0.01%

Questions About CURLF

What is the current price of Curaleaf?

Curaleaf is trading at $9.35 per share.

What is the 52-week range for Curaleaf?

Over the past 52 weeks, Curaleaf has traded between $2.92 and $15.15.

How much debt does Curaleaf have?

As of the most recent reporting period, Curaleaf reported total debt of $1.04B.

How much cash does Curaleaf have on hand?

Curaleaf reported $106.13M in cash and cash equivalents in its most recent financial results.

What is Curaleaf’s dividend yield?

Curaleaf does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services